1. Home
  2. OCUL vs ITGR Comparison

OCUL vs ITGR Comparison

Compare OCUL & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • ITGR
  • Stock Information
  • Founded
  • OCUL 2006
  • ITGR 1970
  • Country
  • OCUL United States
  • ITGR United States
  • Employees
  • OCUL N/A
  • ITGR N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • OCUL Health Care
  • ITGR Health Care
  • Exchange
  • OCUL Nasdaq
  • ITGR Nasdaq
  • Market Cap
  • OCUL 2.3B
  • ITGR 2.4B
  • IPO Year
  • OCUL 2014
  • ITGR 2000
  • Fundamental
  • Price
  • OCUL $12.24
  • ITGR $67.62
  • Analyst Decision
  • OCUL Strong Buy
  • ITGR Buy
  • Analyst Count
  • OCUL 10
  • ITGR 8
  • Target Price
  • OCUL $22.33
  • ITGR $93.14
  • AVG Volume (30 Days)
  • OCUL 2.1M
  • ITGR 2.1M
  • Earning Date
  • OCUL 11-04-2025
  • ITGR 10-23-2025
  • Dividend Yield
  • OCUL N/A
  • ITGR N/A
  • EPS Growth
  • OCUL N/A
  • ITGR N/A
  • EPS
  • OCUL N/A
  • ITGR 2.42
  • Revenue
  • OCUL $55,783,000.00
  • ITGR $1,831,074,000.00
  • Revenue This Year
  • OCUL N/A
  • ITGR $9.69
  • Revenue Next Year
  • OCUL $17.75
  • ITGR $0.48
  • P/E Ratio
  • OCUL N/A
  • ITGR $27.90
  • Revenue Growth
  • OCUL N/A
  • ITGR 9.54
  • 52 Week Low
  • OCUL $5.79
  • ITGR $62.00
  • 52 Week High
  • OCUL $13.85
  • ITGR $146.36
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 59.26
  • ITGR 31.98
  • Support Level
  • OCUL $11.08
  • ITGR $66.00
  • Resistance Level
  • OCUL $12.03
  • ITGR $71.38
  • Average True Range (ATR)
  • OCUL 0.53
  • ITGR 2.20
  • MACD
  • OCUL 0.13
  • ITGR 1.11
  • Stochastic Oscillator
  • OCUL 89.86
  • ITGR 60.02

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About ITGR Integer Holdings Corporation

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.

Share on Social Networks: